<DOC>
	<DOCNO>NCT00971997</DOCNO>
	<brief_summary>The purpose evaluate proportion subject achieve Hemoglobin A1c ( HbA1c ) level 6.5 % , lispro mix 50/50 introduce stepwise manner every day ( QD ) administration type 2 diabetic patient fail achieve adequate glycemic control oral antidiabetic drug ( OADs ) .</brief_summary>
	<brief_title>A Study Insulin Lispro Mix Type 2 Diabetic Asian Patients</brief_title>
	<detailed_description>A multicenter , non-randomized , open-label , post-marketing clinical study . The target population study type 2 diabetic patient fail achieve adequate glycemic control OADs . The study consist 4 period : Lead-in Period ( 2 4 week ) , Study Period I ( 16 week ) , Study Period II ( 16 week ) , Study Period III ( 16 week ) . The regimen lispro mix 50/50 injection change every 16 week base HbA1c level . During Study Period I , subject give daily ( QD ) injection lispro mix 50/50 . During Study Period II , regimen lispro mix 50/50 injection change twice daily ( BID ) HbA1c level Week 16 6.5 % , QD injection continue value 6.5 % . During Study Period III , HbA1c level Week 32 6.5 % , subject BID treatment previous period ( Study Period II ) receive three time daily ( TID ) injection insulin .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<criteria>Patients diagnose type 2 Diabetes . Patients insulin treatment within 6 month . Patients take OADs least 90 day . Patients HbA1c level range 7.5 % 11.0 % . Patients BodyMass Index ( BMI ) 35 kg/mÂ² . Patients preproliferative proliferative retinopathy ( except old retinopathy need treatment ) . Patients suspected malignancy Patients serious complication heart , liver , kidney . Patients hypersensitive allergic insulin insulin analog preparation history . Patients receive systemic steroid . Are currently enrol clinical trial nonapproved drug . Or patient participated clinical trial include postmarketing clinical trial within 90 day prior informed consent obtain . Patients childbearing potential . Breastfeeding patient . Patients positive result pregnancy test perform woman childbearing potential .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>